BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 23170786)

  • 1. Experimental therapy for lung cancer: umbilical cord-derived mesenchymal stem cell-mediated interleukin-24 delivery.
    Zhang X; Zhang L; Xu W; Qian H; Ye S; Zhu W; Cao H; Yan Y; Li W; Wang M; Wang W; Zhang R
    Curr Cancer Drug Targets; 2013 Jan; 13(1):92-102. PubMed ID: 23170786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
    Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
    Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced tumor growth inhibition by mesenchymal stem cells derived from iPSCs with targeted integration of interleukin24 into rDNA loci.
    Liu B; Chen F; Wu Y; Wang X; Feng M; Li Z; Zhou M; Wang Y; Wu L; Liu X; Liang D
    Oncotarget; 2017 Jun; 8(25):40791-40803. PubMed ID: 28388559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells as a novel carrier for targeted delivery of gene in cancer therapy based on nonviral transfection.
    Hu YL; Huang B; Zhang TY; Miao PH; Tang GP; Tabata Y; Gao JQ
    Mol Pharm; 2012 Sep; 9(9):2698-709. PubMed ID: 22862421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy.
    Kim SM; Oh JH; Park SA; Ryu CH; Lim JY; Kim DS; Chang JW; Oh W; Jeun SS
    Stem Cells; 2010 Dec; 28(12):2217-28. PubMed ID: 20945331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pigment epithelial-derived factor and melanoma differentiation associated gene-7 cytokine gene therapies delivered by adipose-derived stromal/mesenchymal stem cells are effective in reducing prostate cancer cell growth.
    Zolochevska O; Yu G; Gimble JM; Figueiredo ML
    Stem Cells Dev; 2012 May; 21(7):1112-23. PubMed ID: 21671747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human umbilical cord mesenchymal stem cells as vehicles of CD20-specific TRAIL fusion protein delivery: a double-target therapy against non-Hodgkin's lymphoma.
    Yan C; Li S; Li Z; Peng H; Yuan X; Jiang L; Zhang Y; Fan D; Hu X; Yang M; Xiong D
    Mol Pharm; 2013 Jan; 10(1):142-51. PubMed ID: 23121392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid enhances anti-tumor effect of mesenchymal stem cell mediated HSV-TK gene therapy in intracranial glioma.
    Ryu CH; Park KY; Kim SM; Jeong CH; Woo JS; Hou Y; Jeun SS
    Biochem Biophys Res Commun; 2012 May; 421(3):585-90. PubMed ID: 22525671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmacytoma model.
    Sartoris S; Mazzocco M; Tinelli M; Martini M; Mosna F; Lisi V; Indraccolo S; Moserle L; Cestari T; Riviera AP; Bifari F; Tridente G; Pizzolo G; Krampera M
    Stem Cells Dev; 2011 Apr; 20(4):709-19. PubMed ID: 20695752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell surface structures influence lung clearance rate of systemically infused mesenchymal stromal cells.
    Nystedt J; Anderson H; Tikkanen J; Pietilä M; Hirvonen T; Takalo R; Heiskanen A; Satomaa T; Natunen S; Lehtonen S; Hakkarainen T; Korhonen M; Laitinen S; Valmu L; Lehenkari P
    Stem Cells; 2013 Feb; 31(2):317-26. PubMed ID: 23132820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Umbilical cord-derived mesenchymal stromal/stem cells expressing IL-24 induce apoptosis in gliomas.
    Fan S; Gao H; Ji W; Zhu F; Sun L; Liu Y; Zhang S; Xu Y; Yan Y; Gao Y
    J Cell Physiol; 2020 Feb; 235(2):1769-1779. PubMed ID: 31301067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of transgenic mesenchymal stem cells engineered to mediate anti-high mobility group box 1 activity: targeting of colon cancer.
    Kikuchi H; Yagi H; Hasegawa H; Ishii Y; Okabayashi K; Tsuruta M; Hoshino G; Takayanagi A; Kitagawa Y
    J Surg Res; 2014 Jul; 190(1):134-43. PubMed ID: 24679698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation.
    Friedman R; Betancur M; Boissel L; Tuncer H; Cetrulo C; Klingemann H
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1477-86. PubMed ID: 18022578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRAIL-expressing gingival-derived mesenchymal stem cells inhibit tumorigenesis of tongue squamous cell carcinoma.
    Xia L; Peng R; Leng W; Jia R; Zeng X; Yang X; Fan M
    J Dent Res; 2015 Jan; 94(1):219-28. PubMed ID: 25391621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mda-7/IL-24 induces apoptosis in human GBC-SD gallbladder carcinoma cells via mitochondrial apoptotic pathway.
    Jia J; Li S; Gong W; Ding J; Fang C; Quan Z
    Oncol Rep; 2011 Jan; 25(1):195-201. PubMed ID: 21109977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human adipose tissue-derived mesenchymal stem cells inhibit T-cell lymphoma growth in vitro and in vivo.
    Ahn JO; Chae JS; Coh YR; Jung WS; Lee HW; Shin IS; Kang SK; Youn HY
    Anticancer Res; 2014 Sep; 34(9):4839-47. PubMed ID: 25202065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells.
    Kanehira M; Xin H; Hoshino K; Maemondo M; Mizuguchi H; Hayakawa T; Matsumoto K; Nakamura T; Nukiwa T; Saijo Y
    Cancer Gene Ther; 2007 Nov; 14(11):894-903. PubMed ID: 17693990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of bone marrow-derived mesenchymal stem cells producing pigment epithelium-derived factor in lung carcinoma.
    Chen Q; Cheng P; Yin T; He H; Yang L; Wei Y; Chen X
    Int J Mol Med; 2012 Sep; 30(3):527-34. PubMed ID: 22684097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptin-modified human mesenchymal stem cells inhibit growth of lung carcinoma in nude mice.
    Du J; Zhang Y; Xu C; Xu X
    Mol Med Rep; 2015 Jul; 12(1):1023-9. PubMed ID: 25816208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.